Latest News & Features
Americas
Bayer and Onyx Pharmaceuticals have sued generic drug maker Mylan in an attempt to stop it from developing a version of liver cancer drug Nexavar. 3 February 2015
Americas
Pharmaceutical company Eli Lilly has reported that its US revenue in 2014 dipped by 29% compared to the previous year, laying the blame on key patents, including those for Cymbalta and Evista, expiring. 3 February 2015
Americas
The US Federal Trade Commission has given the green light for Sun Pharmaceutical to merge with Indian generic drug maker Ranbaxy for $4 billion. 2 February 2015
Americas
AstraZeneca has sued Glenmark Pharmaceuticals for allegedly infringing four patents protecting its breast cancer drug Faslodex. 2 February 2015
Americas
Despite the headwinds facing the industry, a growing number of leading pharmaceutical companies feature on Thomson Reuters’ annual Top 100 Global Innovators list, as Bob Stembridge reports. 30 January 2015
Americas
Existing portfolios should be carefully reviewed and care must be taken in drafting new patent applications to withstand section 101 scrutiny in the US, as Judith Kim, director, and Scott Schaller, of counsel, at Sterne Kessler Goldstein & Fox, describe. 30 January 2015
Americas
The most recent Illicit Trade Report states that pharmaceuticals are by far the most numerous counterfeit commodity reported, and the problem is increasing. LSIPR investigates what’s being done about it. 30 January 2015
article
Think of the word ‘counterfeit’ and your mind is likely to conjure up images of poorly made electronic goods, branded merchandise missing a letter or two, or market traders selling goods whose prices seem too good to be true. 30 January 2015
Generics
The US Food and Drug Administration has approved an application by pharmaceutical company Teva to market a generic version of AstraZeneca’s heartburn drug Nexium. 30 January 2015
Big Pharma
US pharmaceutical company Pfizer has reported that last year it saw a drop in sales revenue and has blamed it on the loss of certain important patents. 29 January 2015